Emerald Bioscience Inc (EMBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EMBI | LGVN | SER | ||
| Company | Emerald Bioscience Inc | Longeveron Inc | Serina Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE Arca | ||
| Open | 0.0925 | 1.0400 | 1.9700 | ||
| High | 0.1000 | 1.1500 | 2.1200 | ||
| Low | 0.0880 | 1.0250 | 1.8700 | ||
| Latest | 0.0900 | 1.1200 | 2.1200 | ||
| Change | +0.0015 | +0.0800 | +0.1800 | ||
| % Change | +1.69% | +7.69% | +9.28% | ||
| Volume | 6,962,700 | 1,502,936 | 591,944 | ||
| 20-Day Average Volume | 9,515,021 | 16,080,637 | 9,972,772 | ||
| Previous Close | 0.0885 | 1.0400 | 1.9400 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.0514 | 0.8856 | 1.9685 | ||
| 20-Day Raw Stochastic | 65.09% | 86.58% | 43.48% | ||
| 20-Day Relative Strength | 72.36 | 65.87 | 50.02 | ||
| Weighted Alpha | -49.22 | -8.45 | -72.02 | ||
| Today's Opinion | 32% Buy | 56% Buy | 80% Sell | ||
| Previous Opinion | 24% Buy | 56% Buy | 96% Sell | ||
| Last Month's Opinion | 88% Sell | 72% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +119.51% since 01/08/21 | +15.10% since 03/25/26 | -30.03% since 03/25/26 | ||
| Low | 0.0400 on 01/11/21 | 0.8760 on 03/27/26 | 1.7501 on 03/30/26 | ||
| High | 0.1195 on 01/13/21 | 1.1500 on 04/01/26 | 2.9000 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +166.27% since 12/15/20 | +106.87% since 02/27/26 | +17.78% since 02/27/26 | ||
| Low | 0.0327 on 12/16/20 | 0.4750 on 03/06/26 | 1.2200 on 03/18/26 | ||
| High | 0.1195 on 01/13/21 | 1.2200 on 03/16/26 | 3.2900 on 03/23/26 | ||
| 3-Month | |||||
| %Chg | +114.29% since 10/15/20 | +121.34% since 12/31/25 | +10.82% since 12/31/25 | ||
| Low | 0.0245 on 12/09/20 | 0.4750 on 03/06/26 | 1.2200 on 03/18/26 | ||
| High | 0.1195 on 01/13/21 | 1.2200 on 03/16/26 | 4.0800 on 01/29/26 | ||
| 6-Month | |||||
| %Chg | -27.94% since 07/15/20 | +50.86% since 10/01/25 | -59.62% since 10/01/25 | ||
| Low | 0.0245 on 12/09/20 | 0.4750 on 03/06/26 | 1.2200 on 03/18/26 | ||
| High | 0.1270 on 07/16/20 | 1.2200 on 03/16/26 | 5.8300 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 24,127 | 24,199 | 23,889 | ||
| Shares Outstanding, K | 268,074 | 23,268 | 12,314 | ||
| Annual Sales | 0 | 1,200,000 | 130,000 | ||
| Annual Net Income | 1,050,000 | -22,700,000 | -19,180,000 | ||
| Last Quarter Sales | N/A | 370,000 | 0 | ||
| Last Quarter Net Income | N/A | -5,440,000 | -4,590,000 | ||
| 60-Month Beta | 0.43 | 0.23 | 1.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.22 on 03/17/26 | -0.31 on 03/25/26 | ||
| Latest Earnings Date | 03/19/21 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||